5,560
Views
130
CrossRef citations to date
0
Altmetric
Research Articles

An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets

, ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 3244-3255 | Received 13 Apr 2020, Accepted 24 Apr 2020, Published online: 13 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (58)

Jiwei Zhang, Chuanfeng Liu, Ruifang Jia, Xujie Zhang, Jian Zhang, Chiara Bertagnin, Anna Bonomini, Laura Guizzo, Yuanmin Jiang, Huinan Jia, Shuzhen Jia, Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan & Xinyong Liu. (2023) A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Vaishali Gurjar, Saiyada Iqra Kamil, Anshuman Chandra, Imteyaz Qamar & Nagendra Singh. (2023) Drugs swapping in coronavirus strains: a structural biology view. Journal of Biomolecular Structure and Dynamics 41:22, pages 13488-13495.
Read now
Aparna Ganapathy Vilasam Sreekala, Krishna Kant Gupta & Vinod Kumar Nathan. (2023) Identification of coastal pesticide pollutants as potent inhibitors of Bacillus pasteurii urease mediated calcium carbonate precipitation: a computational approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-11.
Read now
Ibrahim M. Ibrahim, Abdo A. Elfiky, Sara H. Mahmoud & Mahmoud ElHefnawi. (2023) A structural-based virtual screening and in vitro validation reveals novel effective inhibitors for SARS-CoV-2 helicase and endoribonuclease. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Wahyu Eko Prasetyo, Heri Purnomo, Miracle Sadrini, Fajar Rakhman Wibowo, Maulidan Firdaus & Triana Kusumaningsih. (2023) Identification of potential bioactive natural compounds from Indonesian medicinal plants against 3-chymotrypsin-like protease (3CLpro) of SARS-CoV-2: molecular docking, ADME/T, molecular dynamic simulations, and DFT analysis. Journal of Biomolecular Structure and Dynamics 41:10, pages 4467-4484.
Read now
Tanushree Das & Chaitali Mukhopadhyay. (2023) Computational studies suggest compounds restoring function of p53 cancer mutants can bind SARS-CoV-2 spike protein. Journal of Biomolecular Structure and Dynamics 41:8, pages 3368-3381.
Read now
Soham Seal, Nilanjan Banerjee, Rohit Mahato, Tanmoy Kundu, Debabrata Sinha, Tushar Chakraborty, Debasmita Sinha, Keya Sau, Subhrangsu Chatterjee & Subrata Sau. (2023) Serine 106 preserves the tertiary structure, function, and stability of a cyclophilin from Staphylococcus aureus. Journal of Biomolecular Structure and Dynamics 41:4, pages 1479-1494.
Read now
Essam S. A. E. H. Khattab, Ahmed Ragab, Mahmoud A. Abol-Ftouh & Ahmed A. Elhenawy. (2022) Therapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral spike proteins. Journal of Biomolecular Structure and Dynamics 40:23, pages 13291-13309.
Read now
Dwi Syah Fitra Ramadhan, Fatmasari Siharis, Syawal Abdurrahman, Muhammad Isrul & Taufik Muhammad Fakih. (2022) In silico analysis of marine natural product from sponge (Clathria Sp.) for their activity as inhibitor of SARS-CoV-2 Main Protease. Journal of Biomolecular Structure and Dynamics 40:22, pages 11526-11532.
Read now
Mejdi Snoussi, Alaeddine Redissi, Amor Mosbah, Vincenzo De Feo, Mohd Adnan, Kaïss Aouadi, Mousa Alreshidi, Mitesh Patel, Adel Kadri & Emira Noumi. (2022) Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies. Journal of Biomolecular Structure and Dynamics 40:20, pages 10122-10135.
Read now
Chirag N. Patel, Dweipayan Goswami, Prasanth Kumar Sivakumar & Himanshu A. Pandya. (2022) Repurposing of anticancer phytochemicals for identifying potential fusion inhibitor for SARS-CoV-2 using molecular docking and molecular dynamics (MD) simulations. Journal of Biomolecular Structure and Dynamics 40:17, pages 7744-7761.
Read now
Debasis Mitra, Devvret Verma, Bhaswatimayee Mahakur, Anshul Kamboj, Rakesh Srivastava, Sugam Gupta, Ajita Pandey, Bhawna Arora, Kumud Pant, P. Panneerselvam, Arabinda Ghosh, Durga P. Barik & Pradeep K. Das Mohapatra. (2022) Molecular docking and simulation studies of natural compounds of Vitex negundo L. against papain-like protease (PLpro) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world. Journal of Biomolecular Structure and Dynamics 40:12, pages 5665-5686.
Read now
Pukar Khanal, Rupesh Chikhale, Yadu Nandan Dey, Ismail Pasha, Sharad Chand, Nilambari Gurav, Muniappan Ayyanar, B. M. Patil & Shailendra Gurav. (2022) Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19. Journal of Biomolecular Structure and Dynamics 40:12, pages 5295-5308.
Read now
Abha Mishra, Upinder Kaur & Amit Singh. (2022) Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study. Journal of Biomolecular Structure and Dynamics 40:11, pages 5128-5137.
Read now
Debasmita Sinha, Debabrata Sinha, Nilanjan Banerjee, Priya Rai, Soham Seal, Tushar Chakraborty, Subhrangsu Chatterjee & Subrata Sau. (2022) A conserved arginine residue in a staphylococcal anti-sigma factor is required to preserve its kinase activity, structure, and stability. Journal of Biomolecular Structure and Dynamics 40:11, pages 4972-4986.
Read now
Zoya Khalid & Hammad Naveed. (2022) Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms. Journal of Biomolecular Structure and Dynamics 40:3, pages 1205-1215.
Read now
Zouhair Elkarhat, Hicham Charoute, Lamiae Elkhattabi, Abdelhamid Barakat & Hassan Rouba. (2022) Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses. Journal of Biomolecular Structure and Dynamics 40:1, pages 361-374.
Read now
Aniket Sharma, Shubham Goyal, Arvind Kumar Yadav, Pawan Kumar & Lovely Gupta. (2022) In-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15 proteins of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:1, pages 86-100.
Read now
Abdus Samad, Foysal Ahammad, Zulkar Nain, Rahat Alam, Raihan Rahman Imon, Mahadi Hasan & Md. Shahedur Rahman. (2022) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. Journal of Biomolecular Structure and Dynamics 40:1, pages 14-30.
Read now
Vipul Kumar, Jaspreet Kaur Dhanjal, Priyanshu Bhargava, Ashish Kaul, Jia Wang, Huayue Zhang, Sunil C. Kaul, Renu Wadhwa & Durai Sundar. (2022) Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. Journal of Biomolecular Structure and Dynamics 40:1, pages 1-13.
Read now
Soumita Mukherjee, Subrata Dasgupta, Tapasendra Adhikary, Utpal Adhikari & Sujit Sankar Panja. (2021) Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study. Journal of Biomolecular Structure and Dynamics 39:18, pages 7322-7334.
Read now
Viswanathan Vijayan, Pradeep Pant, Naval Vikram, Punit Kaur, T. P. Singh, Sujata Sharma & Pradeep Sharma. (2021) Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study. Journal of Biomolecular Structure and Dynamics 39:17, pages 6713-6727.
Read now
Pradeep Sharma, Viswanathan Vijayan, Pradeep Pant, Mohita Sharma, Naval Vikram, Punit Kaur, T. P. Singh & Sujata Sharma. (2021) Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:17, pages 6649-6659.
Read now
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour & Danial Gholamin. (2021) Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Journal of Biomolecular Structure and Dynamics 39:17, pages 6633-6648.
Read now
Preeti Pandey, Jitendra Subhash Rane, Aroni Chatterjee, Abhijeet Kumar, Rajni Khan, Amresh Prakash & Shashikant Ray. (2021) Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. Journal of Biomolecular Structure and Dynamics 39:16, pages 6306-6316.
Read now
Satyam Singh, Md Fulbabu Sk, Avinash Sonawane, Parimal Kar & Sushabhan Sadhukhan. (2021) Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp) inhibition: an in-silico analysis. Journal of Biomolecular Structure and Dynamics 39:16, pages 6249-6264.
Read now
Devashan Naidoo, Ayan Roy, Pallab Kar, Taurai Mutanda & Akash Anandraj. (2021) Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis. Journal of Biomolecular Structure and Dynamics 39:16, pages 6218-6230.
Read now
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, Asheet Kumar Nath, Hemant Darbari & Rajendra Joshi. (2021) Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro). Journal of Biomolecular Structure and Dynamics 39:15, pages 5735-5755.
Read now
Abdullah G. Al-Sehemi, Mehboobali Pannipara, Rishikesh S. Parulekar, Omkar Patil, Prafulla B. Choudhari, M. S. Bhatia, P. K. Zubaidha & Yasinalli Tamboli. (2021) Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis. Journal of Biomolecular Structure and Dynamics 39:15, pages 5804-5818.
Read now
Santanu Sasidharan, Chandrabose Selvaraj, Sanjeev Kumar Singh, Vikash Kumar Dubey, Sachin Kumar, Arsenio M. Fialho & Prakash Saudagar. (2021) Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 39:15, pages 5706-5721.
Read now
Rupesh V. Chikhale, Saurabh K. Sinha, Rajesh B. Patil, Satyendra K. Prasad, Anshul Shakya, Nilambari Gurav, Rupali Prasad, Suhas R. Dhaswadikar, Manish Wanjari & Shailendra S. Gurav. (2021) In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. Journal of Biomolecular Structure and Dynamics 39:14, pages 5033-5047.
Read now
Pallab Kar, Neeta Raj Sharma, Bhupender Singh, Arnab Sen & Ayan Roy. (2021) Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. Journal of Biomolecular Structure and Dynamics 39:13, pages 4774-4785.
Read now
Sk. Abdul Amin, Kalyan Ghosh, Shovanlal Gayen & Tarun Jha. (2021) Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors. Journal of Biomolecular Structure and Dynamics 39:13, pages 4764-4773.
Read now
K. G. Arun, C. S Sharanya, J. Abhithaj, Dileep Francis & C. Sadasivan. (2021) Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics 39:13, pages 4647-4658.
Read now
Elham Tazikeh-Lemeski, Sajad Moradi, Rahim Raoufi, Mohsen Shahlaei, Mehr Ali Mahmood Janlou & Samaneh Zolghadri. (2021) Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study. Journal of Biomolecular Structure and Dynamics 39:13, pages 4633-4646.
Read now
Saurabh K. Sinha, Satyendra K. Prasad, Md Ataul Islam, Shailendra S. Gurav, Rajesh B. Patil, Nora Abdullah AlFaris, Tahany Saleh Aldayel, Nora M. AlKehayez, Saikh Mohammad Wabaidur & Anshul Shakya. (2021) Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study. Journal of Biomolecular Structure and Dynamics 39:13, pages 4686-4700.
Read now
Durgesh Kumar, Kamlesh Kumari, Vijay Kumar Vishvakarma, Abhilash Jayaraj, Dhiraj Kumar, Venkatesh Kumar Ramappa, Rajan Patel, Vinod Kumar, Sujata K. Dass, Ramesh Chandra & Prashant Singh. (2021) Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 39:13, pages 4671-4685.
Read now
D. S. N. B. K. Prasanth, Manikanta Murahari, Vivek Chandramohan, Siva Prasad Panda, Lakshmana Rao Atmakuri & Chakravarthi Guntupalli. (2021) In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. Journal of Biomolecular Structure and Dynamics 39:13, pages 4618-4632.
Read now
Selvaraj Alagu Lakshmi, Raja Mohamed Beema Shafreen, Arumugam Priya & Karutha Pandian Shunmugiah. (2021) Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach. Journal of Biomolecular Structure and Dynamics 39:13, pages 4594-4609.
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 39:12, pages 4362-4374.
Read now
Rupesh V. Chikhale, Shailendra S. Gurav, Rajesh B. Patil, Saurabh K. Sinha, Satyendra K. Prasad, Anshul Shakya, Sushant K. Shrivastava, Nilambari S. Gurav & Rupali S. Prasad. (2021) Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. Journal of Biomolecular Structure and Dynamics 39:12, pages 4510-4521.
Read now
Mark Tristan J. Quimque, Kin Israel R. Notarte, Rey Arturo T. Fernandez, Mark Andrew O. Mendoza, Rhenz Alfred D. Liman, Justin Allen K. Lim, Luis Agustin E. Pilapil, Jehiel Karsten H. Ong, Adriel M. Pastrana, Abbas Khan, Dong-Qing Wei & Allan Patrick G. Macabeo. (2021) Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics 39:12, pages 4316-4333.
Read now
Anshuman Chandra, Vaishali Gurjar, Imteyaz Qamar & Nagendra Singh. (2021) Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19. Journal of Biomolecular Structure and Dynamics 39:12, pages 4201-4211.
Read now
Muhammad Hamza, Ashaq Ali, Suliman Khan, Saeed Ahmed, Zarlish Attique, Saad Ur Rehman, Ayesha Khan, Hussain Ali, Muhammad Rizwan, Anum Munir, Arshad Mehmood Khan, Faiza Siddique, Azhar Mehmood, Faisal Nouroz & Sajid Khan. (2021) nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine. Journal of Biomolecular Structure and Dynamics 39:11, pages 4089-4099.
Read now
Firoz Anwar, Hisham N. Altayb, Fahad A. Al-Abbasi, Abdulrahman L. Al-Malki, Mohammad Amjad Kamal & Vikas Kumar. (2021) Antiviral effects of probiotic metabolites on COVID-19. Journal of Biomolecular Structure and Dynamics 39:11, pages 4175-4184.
Read now
Mohamed A. Hendaus & Fatima A. Jomha. (2021) Covid-19 induced superimposed bacterial infection. Journal of Biomolecular Structure and Dynamics 39:11, pages 4185-4191.
Read now
Vipul Kumar, Jaspreet Kaur Dhanjal, Sunil C. Kaul, Renu Wadhwa & Durai Sundar. (2021) Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Journal of Biomolecular Structure and Dynamics 39:11, pages 3842-3854.
Read now
Mohd. Iqbal Yatoo, Zeenat Hamid, Izhar Rather, Qurat Ul Ain Nazir, Riyaz Ahmed Bhat, Abrar Ul Haq, Suhail Nabi Magray, Zulfqar Haq, Ranjit Sah, Ruchi Tiwari, SenthilKumar Natesan, Muhammad Bilal, Harapan Harapan & Kuldeep Dhama. (2021) Immunotherapies and immunomodulatory approaches in clinical trials - a mini review. Human Vaccines & Immunotherapeutics 17:7, pages 1897-1909.
Read now
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan & Madhu Rathore. (2021) Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. Journal of Biomolecular Structure and Dynamics 39:10, pages 3760-3770.
Read now
Satyajit Beura & Prabhakar Chetti. (2021) In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:10, pages 3747-3759.
Read now
Chinmayee Choudhury. (2021) Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease. Journal of Biomolecular Structure and Dynamics 39:10, pages 3733-3746.
Read now
K. Abraham Peele, T. Srihansa, S. Krupanidhi, Vijaya Sai Ayyagari & T. C. Venkateswarulu. (2021) Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study. Journal of Biomolecular Structure and Dynamics 39:10, pages 3793-3801.
Read now
Muhammad Tahir Khan, Arif Ali, Qiankun Wang, Muhammad Irfan, Abbas Khan, Muhammad Tariq Zeb, Yu-Juan Zhang, Sathishkumar Chinnasamy & Dong-Qing Wei. (2021) Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study. Journal of Biomolecular Structure and Dynamics 39:10, pages 3627-3637.
Read now
Saurov Mahanta, Purvita Chowdhury, Neelutpal Gogoi, Nabajyoti Goswami, Debajit Borah, Rupesh Kumar, Dipak Chetia, Probodh Borah, Alak K. Buragohain & Bhaskarjyoti Gogoi. (2021) Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach. Journal of Biomolecular Structure and Dynamics 39:10, pages 3802-3811.
Read now
Lovika Mittal, Anita Kumari, Mitul Srivastava, Mrityunjay Singh & Shailendra Asthana. (2021) Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure and Dynamics 39:10, pages 3662-3680.
Read now
Md Fulbabu Sk, Rajarshi Roy, Nisha Amarnath Jonniya, Sayan Poddar & Parimal Kar. (2021) Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics 39:10, pages 3649-3661.
Read now
Mohamed A. Hendaus. (2021) Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary. Journal of Biomolecular Structure and Dynamics 39:10, pages 3787-3792.
Read now

Articles from other publishers (72)

Zahra Alipour, Somayeh Zarezadeh & Ali Akbar Ghotbi-Ravandi. (2023) The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review. Planta Medica.
Crossref
Luís Queirós-Reis, João R. Mesquita, Andrea Brancale & Marcella Bassetto. (2023) Exploring the Fatty Acid Binding Pocket in the SARS-CoV-2 Spike Protein – Confirmed and Potential Ligands. Journal of Chemical Information and Modeling.
Crossref
Supriya Sharma, Nisha Nair, Jaseela Majeed, Bhoomika Patel, Vivekanand Mandal & Mahaveer Dhobi. (2023) Critically analyzing the resilience of alternative and complementary medicines as possible COVID-19 intervention: A cross-sectional study based on CTRI database. Journal of Herbal Medicine 41, pages 100730.
Crossref
Ching-Yuan Wu, Yao-Hsu Yang, Yu-Shih Lin, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yin-Yin Lin, I-Yun Lee, Wei-Tai Shih, Pei-Rung Yang, Ying-Ying Tsai, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen & Ming-Shao Tsai. (2023) The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution. Heliyon 9:7, pages e17701.
Crossref
Susankar Kushari, Iswar Hazarika, Damiki Laloo, Suman Kumar, Jun Moni Kalita & Himangshu Sarma. (2022) An integrated computational approach towards the screening of active plant metabolites as potential inhibitors of SARS-CoV-2: an overview. Structural Chemistry 34:3, pages 1073-1104.
Crossref
Kavitha KSrinivasan NSuresh RMohan S. (2023) In Silico Identification of Potential Inhibitors of Substituted Quinazolin-4-One against Main Protease and Spike Glycoprotein of Sars Cov-2. Research Journal of Pharmacy and Technology, pages 2470-2476.
Crossref
Bashir Lawal, Sheng-Kuang Tsai, Alexander T.H. Wu & Hsu-Shan Huang. (2023) In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates. Arabian Journal of Chemistry 16:5, pages 104654.
Crossref
Noel Joseph J., Akansha Shrivastava, Bitto Benny, Mohamed Yusuf Baig, Ann Georgine S. & Mary Saral A.. (2023) Antiviral Properties of Various Bioactive Components Present in the Root of Glycyrrhiza glabra: Review. Current Nutrition & Food Science 19:2, pages 166-175.
Crossref
Shabana Bibi, Fahad ul Islam, Oluwaseyi Abraham Olawale, Muhammad Saad Khan, Hitesh chopra & Santosh Kumar Gupta. 2023. Application of Natural Products in SARS-CoV-2. Application of Natural Products in SARS-CoV-2 463 489 .
Shristi Modanwal & Nidhi Mishra. 2023. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products 115 136 .
Abdirahman Elmi, Ahmed Said Mohamed, Saredo Said & Remy Bationo. 2023. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products 549 573 .
Jiapu ZhangJiapu Zhang. 2023. Optimization-based Molecular Dynamics Studies of SARS-CoV-2 Molecular Structures. Optimization-based Molecular Dynamics Studies of SARS-CoV-2 Molecular Structures 711 721 .
Tai Young Kim, Sangeun Jeon, Meehyun Ko, Young Eun Du, So-Ri Son, Dae Sik Jang, Seungtaek Kim & C. Justin Lee. (2022) Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern. Antimicrobial Agents and Chemotherapy 66:12.
Crossref
Logesh Kumar Selvaraj, Srikanth Jeyabalan, Ling Shing Wong, Mahendran Sekar, B. Logeshwari, S. Umamaheswari, Sree Premkumar, Roshan Tej Sekar, M. Yasmin Begum, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Kumarappan Chidambaram, Vetriselvan Subramaniyan, Adel Al Fatease, Ali Alamri, Kathiresan V. Sathasivam, Siddharthan Selvaraj, Kamini Vijeepallam, Shivkanya Fuloria & Neeraj Kumar Fuloria. (2022) Baicalein prevents stress-induced anxiety behaviors in zebrafish model. Frontiers in Pharmacology 13.
Crossref
Cisem Altunayar-Unsalan, Ozan Unsalan & Thomas Mavromoustakos. (2022) Molecular interactions of hesperidin with DMPC/cholesterol bilayers. Chemico-Biological Interactions 366, pages 110131.
Crossref
Ruifang Jia, Jiwei Zhang, Jian Zhang, Chiara Bertagnin, Anna Bonomini, Laura Guizzo, Zhen Gao, Xiangkai Ji, Zhuo Li, Chuanfeng Liu, Han Ju, Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan & Xinyong Liu. (2022) Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant. Molecules 27:19, pages 6426.
Crossref
Chattarin Ruchawapol, Wen-Wei Fu & Hong-Xi Xu. (2022) A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19. Phytomedicine 104, pages 154324.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Şevki Adem, Volkan Eyupoglu, Ibrahim M. Ibrahim, Iqra Sarfraz, Azhar Rasul, Muhammad Ali & Abdo A. Elfiky. (2022) Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19. Computers in Biology and Medicine 145, pages 105452.
Crossref
Md. Mominur Rahman, Shabana Bibi, Md. Saidur Rahaman, Firoza Rahman, Fahadul Islam, Muhammad Saad Khan, Mohammad Mehedi Hasan, Anwar Parvez, Md. Abid Hossain, Saila Kabir Maeesa, Md. Rezaul Islam, Agnieszka Najda, Hamdan S. Al-malky, Hanan R.H. Mohamed, Hussah I.M. AlGwaiz, Aeshah A. Awaji, Mousa O. Germoush, Osama A. Kensara, Mohamed M. Abdel-Daim, Mohd Saeed & Mohammad Amjad Kamal. (2022) Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology. Biomedicine & Pharmacotherapy 150, pages 113041.
Crossref
Ming-Shao Tsai, Wei-Tai Shih, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen & Ching-Yuan Wu. (2022) Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations. Biomedicine & Pharmacotherapy 149, pages 112802.
Crossref
Ekta Gupta, Rupesh Kumar Mishra & Ravi Ranjan Kumar Niraj. (2022) Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach. JMIR Bioinformatics and Biotechnology 3:1, pages e32401.
Crossref
Behzad Shahbazi, Ladan Mafakher & Ladan Teimoori-Toolabi. (2022) Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study. Journal of Molecular Modeling 28:4.
Crossref
Md. Junaid, Yeasmin Akter, Aysha Siddika, S. M. Abdul Nayeem, Afsana Nahrin, Syeda Samira Afrose, Md. Muzahid Ahmed Ezaj & Muhammad Shaiful Alam. (2022) Nature-Derived Hit, Lead, and Drug-Like Small Molecules: Current Status and Future Aspects Against Key Target Proteins of Coronaviruses. Mini-Reviews in Medicinal Chemistry 22:3, pages 498-549.
Crossref
Yang Liu, Jianhong Gan, Rongqi Wang, Xiaocong Yang, Zhixiong Xiao & Yang Cao. (2022) DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design. Molecules 27:3, pages 683.
Crossref
Abdallah S. Abdelsattar, Zahraa M. El-Awadly, Mai Abdelgawad, Fayrouz Mahmoud, Sahar A. Allam & Mohamed A. Helal. (2021) The Role of Molecular Modeling and Bioinformatics in Treating a Pandemic Disease: The Case of COVID-19. The Open COVID Journal 1:1, pages 216-234.
Crossref
Yusuf Şimşek, Sahra Setenay Baran & Belma Aslım. (2021) In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals. Journal of Molecular Graphics and Modelling 109, pages 108038.
Crossref
Mohammed I. A. Hamed, Khaled M. Darwish, Raya Soltane, Amani Chrouda, Ahmed Mostafa, Noura M. Abo Shama, Sameh S. Elhady, Hamada S. Abulkhair, Ahmed E. Khodir, Ayman Abo Elmaaty & Ahmed A. Al-karmalawy. (2021) β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico , in vitro , and SAR studies for lead optimization . RSC Advances 11:56, pages 35536-35558.
Crossref
Syed Mohd Danish Rizvi, Talib Hussain, Afrasim Moin, Sheshagiri R. Dixit, Subhankar P. Mandal, Mohd Adnan, Qazi Mohammad Sajid Jamal, Dinesh C. Sharma, Abulrahman Sattam Alanazi & Rahamat Unissa. (2021) Identifying the Most Potent Dual-Targeting Compound(s) against 3CLprotease and NSP15exonuclease of SARS-CoV-2 from Nigella sativa: Virtual Screening via Physicochemical Properties, Docking and Dynamic Simulation Analysis. Processes 9:10, pages 1814.
Crossref
Anuj Kumar, Dwijesh Chandra Mishra, Ulavappa Basavanneppa Angadi, Rashmi Yadav, Anil Rai & Dinesh Kumar. (2021) Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study. Frontiers in Chemistry 9.
Crossref
Surjeet Verma, Chirag N. Patel & Muktesh Chandra. (2021) Identification of novel inhibitors of SARS‐CoV ‐2 main protease (M pro ) from Withania sp. by molecular docking and molecular dynamics simulation . Journal of Computational Chemistry 42:26, pages 1861-1872.
Crossref
Wenxi Liu, Xianlong Cheng, Rong Kang, Yadan Wang, Xiaohan Guo, Wenguang Jing, Feng Wei & Shuangcheng Ma. (2021) Systematic Characterization and Identification of Saikosaponins in Extracts From Bupleurum marginatum var. stenophyllum Using UPLC-PDA-Q/TOF-MS. Frontiers in Chemistry 9.
Crossref
Mina Maddah, Roodabeh Bahramsoltani, Nafiseh Hoseini Yekta, Roja Rahimi, Rasoul Aliabadi & Mahdi Pourfath. (2021) Proposing high-affinity inhibitors from Glycyrrhiza glabra L. against SARS-CoV-2 infection: virtual screening and computational analysis . New Journal of Chemistry 45:35, pages 15977-15995.
Crossref
Vaishali Murade, Amit Waghmare, Deepali Pakhare, Sonali Dichayal, Rajesh Patil, Manish Wanjari, Shailendra Gurav & Dinesh Hase. (2021) A plausible involvement of GABAA/benzodiazepine receptor in the anxiolytic-like effect of ethyl acetate fraction and quercetin isolated from Ricinus communis Linn. leaves in mice. Phytomedicine Plus 1:3, pages 100041.
Crossref
Bhaskarjyoti Gogoi, Purvita Chowdhury, Nabajyoti Goswami, Neelutpal Gogoi, Tufan Naiya, Pankaj Chetia, Saurov Mahanta, Dipak Chetia, Bhaben Tanti, Probodh Borah & Pratap Jyoti Handique. (2021) Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Molecular Diversity 25:3, pages 1963-1977.
Crossref
Rupesh Chikhale, Saurabh K. Sinha, Manish Wanjari, Nilambari S. Gurav, Muniappan Ayyanar, Satyendra Prasad, Pukar Khanal, Yadu Nandan Dey, Rajesh B. Patil & Shailendra S. Gurav. (2021) Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis. Molecular Diversity 25:3, pages 1889-1904.
Crossref
Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee & Abu Saleh. (2021) Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective . Future Virology 16:7, pages 467-474.
Crossref
Jafrin Jobayer Sonju, Md. Rafi Anwar, Md. Abul Kalam Azad, Umme Habiba Sultana, Kumar Kulldeep Niloy & Sajan Das. (2021) Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19. Coronaviruses 2:7.
Crossref
Logesh Kumar Selvaraj, Geethanjali Thayumanavan, Srikanth Jeyabalan & Sugin Lal Jabaris. (2021) Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2. Journal of Molecular Docking 1:1, pages 15-24.
Crossref
Chirag N. Patel, Dweipayan Goswami, Dharmesh G. Jaiswal, Robin M. Parmar, Hitesh A. Solanki & Himanshu A. Pandya. (2021) Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations. Journal of Molecular Graphics and Modelling 105, pages 107874.
Crossref
Weiwei Zhou, Yifei Dai, Jing Meng, Pengqian Wang, Yin Wu, Li Dai, Miao Zhang, Xiujuan Yang, Shujun Xu, Feng Sui & Hairu Huo. (2021) Network pharmacology integrated with molecular docking reveals the common experiment-validated antipyretic mechanism of bitter-cold herbs. Journal of Ethnopharmacology 274, pages 114042.
Crossref
Jatin Sharma, Vijay Kumar Bhardwaj, Rahul Singh, Vidya Rajendran, Rituraj Purohit & Sanjay Kumar. (2021) An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2. Food Chemistry 346, pages 128933.
Crossref
Ramachandran Vijayan & Samudrala Gourinath. (2021) Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors. Journal of Proteins and Proteomics 12:2, pages 71-80.
Crossref
Léna Petit, Léa Vernès & Jean-Paul Cadoret. (2021) Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2. Journal of Applied Phycology 33:3, pages 1579-1602.
Crossref
Peng Li, Shuang Hu, Cheng Qian, Yan Yao, Liang-yun Li, Jun-fa Yang, Li Yang, Chen-chen Yang, Hong Zhou, Shu-xian Wang, Ying Hu, Xing-yu Zhu, Jing Zhou, Lin-xin Pan, Chuan-pu Shen & Huan Zhou. (2021) The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19. Frontiers in Pharmacology 12.
Crossref
Shailima Rampogu & Keun Woo Lee. (2021) Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics. Frontiers in Chemistry 9.
Crossref
Murtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, Natália Cruz-Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Aliyu Muhammad, Siew Hua Gan, Aliyu Ibrahim Dabai, M Alblihed, Arabinda Ghosh, Reem H. Badr, Devarajan Thangadurai & Mustapha Umar Imam. (2021) Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies. Frontiers in Pharmacology 12.
Crossref
Xuedong An, YueHong Zhang, Liyun Duan, De Jin, Shenghui Zhao, RongRong Zhou, Yingying Duan, Fengmei Lian & Xiaolin Tong. (2021) The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19. Biomedicine & Pharmacotherapy 137, pages 111267.
Crossref
Shailima Rampogu, Gihwan Lee, Apoorva M. Kulkarni, Donghwan Kim, Sanghwa Yoon, Myeong Ok Kim & Keun Woo Lee. (2021) Computational Approaches to Discover Novel Natural Compounds for SARS‐CoV‐2 Therapeutics. ChemistryOpen 10:5, pages 593-599.
Crossref
G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, Haseeb A. Khan, Salman H. Alrokayan & N. Rajendra Prasad. (2021) SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Frontiers in Pharmacology 12.
Crossref
SABYASACHI SENAPATI, PRATIBHA BANERJEE, SANDILYA BHAGAVATULA, PREM PRAKASH KUSHWAHA & SHASHANK KUMAR. (2021) Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19. Journal of Genetics 100:1.
Crossref
Esraa M. O. A. Ismail, Shaza W. Shantier, Mona S. Mohammed, Hassan H. Musa, Wadah Osman & Ramzi A. Mothana. (2021) Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach. Journal of Chemistry 2021, pages 1-11.
Crossref
Serena Dotolo, Anna Marabotti, Angelo Facchiano & Roberto Tagliaferri. (2021) A review on drug repurposing applicable to COVID-19. Briefings in Bioinformatics 22:2, pages 726-741.
Crossref
Muthu Kumaradoss Kathiravan, Srimathi Radhakrishnan, Vigneshwaran Namasivayam & Senthilkumar Palaniappan. (2021) An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus. Frontiers in Molecular Biosciences 8.
Crossref
U. Rutwick Surya & N. Praveen. (2021) A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery. VirusDisease 32:1, pages 46-54.
Crossref
Pukar Khanal, Taaza Duyu, B. M. Patil, Yadu Nandan Dey, Ismail Pasha, Rohini S. Kavalapure, Sharad Chand & Shailendra Gurav. (2021) Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology. 3 Biotech 11:3.
Crossref
Christian Gomez, Ingrid Espinoza, Fazlay Faruque, Md. Mahbub Hasan, Khondaker Rahman, Larry Walker & Ilias Muhammad. (2021) Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach. Molecules 26:4, pages 1191.
Crossref
Pukar Khanal, Yadu Nandan Dey, Rajesh Patil, Rupesh Chikhale, Manish M. Wanjari, Shailendra S. Gurav, B. M. Patil, Bhavana Srivastava & Sudesh N. Gaidhani. (2021) Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19. RSC Advances 11:9, pages 5065-5079.
Crossref
Monica C. Pillon, Meredith N. Frazier, Lucas B. Dillard, Jason G. Williams, Seda Kocaman, Juno M. Krahn, Lalith Perera, Cassandra K. Hayne, Jacob Gordon, Zachary D. Stewart, Mack Sobhany, Leesa J. Deterding, Allen L. Hsu, Venkata P. Dandey, Mario J. Borgnia & Robin E. Stanley. (2021) Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics. Nature Communications 12:1.
Crossref
Tofael Ahmed Sumon, Md. Ashraf Hussain, Md. Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, Abdullah Al Mamun Chowdhury, S. M. Sharifuzzaman, Christopher Lyon Brown, Hyun-Ju Kwon & Eun-Woo Lee. (2021) A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic. Frontiers in Molecular Biosciences 7.
Crossref
Sajad Fakhri, Sana Piri, Mohammad Bagher Majnooni, Mohammad Hosein Farzaei & Javier Echeverría. (2021) Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Frontiers in Pharmacology 11.
Crossref
Ze-Jia Song, WanNajbah Nik Nabil, Zhi-Chao Xi & Hong-Xi Xu. (2021) Current global status and future development of traditional Chinese medicine in the prevention and treatment of Coronavirus Disease 2019. World Journal of Traditional Chinese Medicine 0:0, pages 0.
Crossref
Rashed Noor. (2021) Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic. Tzu Chi Medical Journal 33:1, pages 7.
Crossref
Gourab Das, Troyee Das, Nilkanta Chowdhury, Durbadal Chatterjee, Angshuman Bagchi & Zhumur Ghosh. (2021) Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19. Genomics 113:1, pages 1129-1140.
Crossref
Rajesh Patil, Rupesh Chikhale, Pukar Khanal, Nilambari Gurav, Muniappan Ayyanar, Saurabh Sinha, Satyendra Prasad, Yadu Nandan Dey, Manish Wanjari & Shailendra S. Gurav. (2021) Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19. Informatics in Medicine Unlocked 22, pages 100504.
Crossref
Shokouh Rezaei & Yahya Sefidbakht. 2021. COVID-19. COVID-19 91 120 .
Valerie Bríd O’Leary, Oliver James Dolly, Cyril Höschl, Marie Černa & Saak Victor Ovsepian. (2020) Unpacking Pandora from Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. International Journal of Molecular Sciences 22:1, pages 386.
Crossref
Shravan B. Rathod, Pravin B. Prajapati, Lata B. Punjabi, Kuntal N. Prajapati, Neha Chauhan & Mohmedyasin F. Mansuri. (2020) Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2. In Silico Pharmacology 8:1.
Crossref
Fai‐Chu Wong, Joe‐Hui Ong & Tsun‐Thai Chai. (2020) Identification of Putative Cell‐entry‐inhibitory Peptides against SARS‐CoV‐2 from Edible Insects: An in silico Study . eFood 1:5, pages 357-368.
Crossref
Eduardo Andrés Tuta-Quintero, Valentina Suárez-Ramirez & Juan Pimentel. (2020) Eficacia y seguridad de la medicina tradicional china en COVID-19: una revisión exploratoria. Revista Internacional de Acupuntura 14:4, pages 132-150.
Crossref
Ahmed Rakib, Saad Ahmed Sami, Nusrat Jahan Mimi, Md. Mustafiz Chowdhury, Taslima Akter Eva, Firzan Nainu, Arkajyoti Paul, Asif Shahriar, Abu Montakim Tareq, Nazim Uddin Emon, Sajal Chakraborty, Sagar Shil, Sabrina Jahan Mily, Taibi Ben Hadda, Faisal A. Almalki & Talha Bin Emran. (2020) Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Computers in Biology and Medicine 124, pages 103967.
Crossref
Nilanjan Adhikari, Sk. Abdul Amin & Tarun Jha. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses 329 431 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.